* Quipt Home Medical Corp QIPT.V is expected to show a
rise in
quarterly revenue when it reports results on February 13.
* The Wilder Kentucky-based company is expected to report
a
42.9% increase in revenue to $42.177 million from $29.53 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Quipt Home Medical
Corp
is for earnings of 5 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Quipt Home
Medical Corp is $10, above its last closing price of $6.18.
This summary was machine generated February 11 at 02:10 GMT.
All figures in US dollars unless otherwise stated